Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.32 USD | -2.81% | -5.44% | +21.58% |
May. 13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.58% | 2.17B | |
-5.86% | 12.09B | |
-4.87% | 8.21B | |
+5.47% | 5.74B | |
+27.81% | 5.64B | |
-9.89% | 4.16B | |
-59.08% | 2.88B | |
+8.97% | 2.69B | |
-5.19% | 2.33B | |
-6.23% | 1.86B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics Shares Rise After Reporting Narrower Q1 Adjusted Loss, Higher Revenue